Step-by-step management of refractory status epilepticus in the ICU

1 Answer

### **Step-by-Step Management of Status Epilepticus (SE) and Refractory SE** The management of SE is a time-critical neurological emergency. Following the **Neurocritical Care Society** and **American Epilepsy Society (AES)** guidelines, the management should proceed in distinct phases. #### 1. Current Phase: Urgent Control (Phase 2) This patient has failed **Phase 1 (Emergent Therapy)** with Lorazepam and one **Phase 2 (Urgent Therapy)** drug (Levetiracetam). * **Next Step:** Guidelines suggest that if the first Phase 2 AED fails, a second different Phase 2 drug should be administered at full weight-based doses. * **Choice of Agent:** Evidence from the **ESETT trial** shows similar efficacy between Levetiracetam, Fosphenytoin, and Valproate. Since Levetiracetam failed, **IV Valproate (40 mg/kg)** or **IV Fosphenytoin (20 mg PE/kg)** are appropriate next steps. **IV Lacosamide (200-400 mg)** is also an increasingly used alternative with a good safety profile. #### 2. Declaring Refractory Status Epilepticus (RSE) * **Point of Declaration:** RSE is defined when SE persists despite adequate doses of a benzodiazepine and at least one (some guidelines say two) Phase 2 antiepileptic drugs. * **Anesthetic Induction:** If the second AED (e.g., Valproate) fails to stop seizures within 20 minutes of administration, the patient is in **RSE**. Anesthetic agents must be initiated immediately: * **Midazolam:** 0.2 mg/kg bolus followed by 0.05-2.0 mg/kg/hr infusion. * **Propofol:** 1-2 mg/kg bolus followed by 30-200 mcg/kg/min (monitoring for Propofol Infusion Syndrome). * **Ketamine:** Often added for NMDA blockade in cases of super-refractory SE. #### 3. Role of Continuous EEG (cEEG) Monitoring cEEG is mandatory in the ICU for any patient being treated for RSE: * **Non-convulsive SE Detection:** Up to 48% of patients with convulsive SE will continue to have electrographic seizures after the physical convulsions stop. * **Titration Goal:** Anesthetics should be titrated to a goal of **electrographic seizure suppression** or **burst-suppression** (e.g., a suppression period of 5-10 seconds). * **Weaning:** cEEG allows for safe weaning of anesthetics by detecting subclinical seizure recurrence. #### 4. Summary Recommendation For this 35-year-old intubated patient: 1. Administer **IV Valproate** or **Fosphenytoin** immediately. 2. Initiate **continuous EEG** monitoring. 3. Prepare for **Propofol or Midazolam** infusion if EEG shows persistent activity 20 minutes after the second AED. **References:** 1. Brophy GM, et al. Guidelines for the Evaluation and Management of Status Epilepticus. *Neurocrit Care*. 2012. 2. Kapur J, et al. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus (ESETT). *N Engl J Med*. 2019. 3. Glauser T, et al. Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society. *Epilepsy Curr*. 2016.